Ziporen, L., Donin, N., Shmushkovich, T., Gross, A. and Fishelson, Z. Programmed necrotic cell death induced by complement involves a Bid-dependent pathway, J. Immunol. 182: 515-521, 2009.
Gancz, D., Donin, N. and Fishelson, Z. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death Molec. Immunol. 47: 310-317, 2009.
Gancz D. and Fishelson Z. Cancer resistance to complement-dependent cytotoxicity (CDC): Problem-oriented research and development. Molec. Immunol. 46: 2794-2800, 2009.
Pilzer D., Saar M., Koya K. and Fishelson Z. Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity. Int. J. Cancer. 126: 1428-1435, 2010.
Oren M., Paz G., Douek J., Rosner A., Fishelson Z., Goulet T.L., Henckel K., and Rinkevich B. 'Rejected' vs. 'rejecting' transcriptomes in allogeneic challenged colonial urochordates. Molec. Immunol. 47: 2083-2093, 2010.
Goldberg M, Fremeaux-Bacchi V, Koch P, Fishelson Z, Katz Y. A novel mutation in the C3 gene and recurrent invasive pneumococcal infection: A clue for vaccine development. Mol. Immunol. 48: 1926-1931, 2011.
Kalmanovich E, Kriger-Sharabi O, Shiloah E, Donin N, Fishelson Z, Rapoport MJ Clostridium difficile infection and partial membrane cofactor protein (CD46) deficiency. Isr. Med. Assoc. J. 14: 586-7, 2012.
Moskovich O, Herzog L-O, Ehrlich M and Fishelson Z. Caveolin-1 and dynamin-2 are essential for removal of the complement C5b-9 complex via endocytosis. J. Biol. Chem. 287: 19904-19915, 2012.
Gancz D, Lusthaus M and Fishelson Z. A role for the NF-κB pathway in cell protection from complement-dependent cytotoxicity, J. Immunol., 189: 860-866, 2012.
Rozenberg P, Kocsis, J, Saar M, Prohászka Z, Füst G, Fishelson Z, Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in colorectal cancer patients, Int. J. Cancer, 2013 (in press).